HealthQuill fatigue
The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.’s drug to treat a specific group of adult lung cancer patients who have tried other systemic treatments.
Drugs Health Pharma

AbbVie’s NSCLC lung cancer drug gets accelerated approval from FDA

 HQ Team May 15, 2025: The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.’s drug to treat.

Read More
The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.
Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating.

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Health Pharma

Ionis Pharma’s drug to treat rare genetic disease gets US regulator’s nod 

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia.

Read More
overuse of cannabis can result in impaired memory
Drugs Health Pharma

FDA clears Akebia’s drug to treat anaemia in acute kidney disease

HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia.

Read More
Covid-19 drug from repurposed liver disease medicine
Drugs Health Medical

New Study gives insights into long COVID symptoms and treatment implications

Some people continue to suffer from the underlying effects of COVID-19, which manifests in the form of poor health. People suffer from anxiety.

Read More